{
    "xml": "<topic id=\"PHP6120\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/magnesium-sulfate\" basename=\"magnesium-sulfate\" title=\"MAGNESIUM SULFATE\">\n<title>MAGNESIUM SULFATE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_608\" namespace=\"/interactions/list-of-drug-interactions/magnesium-parenteral\">Magnesium (parenteral)</xref>\n</p>\n<data name=\"vtmid\">37400007</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_979370732\" title=\"Magnesium\">Magnesium</xref>\n</data>\n</data>\r\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_581331277\" title=\"Osmotic laxatives\">Osmotic laxatives</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n<data name=\"secondaryDomainsOfEffect\">\n<data name=\"domainOfEffect\">  </data>\r\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP71480\" outputclass=\"indicationsAndDose\" rev=\"1.59\" parent=\"/drugs/magnesium-sulfate\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Severe acute asthma</p>\n<p outputclass=\"therapeuticIndication\">Continuing respiratory deterioration in anaphylaxis</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup child\">\n<p>Child 2&#8211;17 years</p>\n<p>40&#8239;mg/kg (max. per dose 2&#8239;g), to be given over 20 minutes.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>1.2&#8211;2&#8239;g, to be given over 20 minutes.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prevention of seizures in pre-eclampsia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 4&#8239;g, to be given over 5&#8211;15 minutes, followed by (by intravenous infusion) 1&#8239;gram/hour for 24 hours, if seizure occurs, additional dose of 2&#8239;g by intravenous injection to be administered.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of seizures and prevention of seizure recurrence in eclampsia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Initially 4&#8239;g, to be given over 5&#8211;15 minutes, followed by (by intravenous infusion) 1&#8239;gram/hour for 24 hours after seizure or delivery (whichever is later), if seizure recurs, increase the infusion rate to 1.5&#8211;2&#8239;g/hour or give an additional dose of 2&#8239;g by intravenous injection.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypomagnesaemia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>Up to 40&#8239;g, dose given over up to 5 days may be required to replace the deficit (allowing for urinary losses).</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Hypomagnesaemia maintenance (e.g. in intravenous nutrition)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion or by intramuscular injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2.5&#8211;5&#8239;g daily, usual dose 3&#8239;g daily.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Emergency treatment of serious arrhythmias</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous injection</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>2&#8239;g, to be given over 10-15 minutes, dose may be repeated once if necessary.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Rapid bowel evacuation (acts in 2&#8211;4 hours)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>5&#8211;10&#8239;g, dose to be mixed in a glass of water, taken preferably before breakfast.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>Magnesium sulfate heptahydrate 1&#8239;g equivalent to Mg<sup>2+</sup> approx. 4&#8239;mmol.</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71403\" outputclass=\"unlicensedUse\" rev=\"1.11\" parent=\"/drugs/magnesium-sulfate\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>Unlicensed indication in severe acute asthma.</p>\n<p>Continuing respiratory deterioration in anaphylaxis.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71577\" outputclass=\"contraindications\" rev=\"1.18\" parent=\"/drugs/magnesium-sulfate\">\n<title>Contra-indications</title>\n<body>\n<section outputclass=\"contraindications\">\n<sectiondiv outputclass=\"additionalContraindications\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"contraindication\">in rapid bowel evacuation&#8212;acute gastro-intestinal conditions</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71597\" outputclass=\"cautions\" rev=\"1.23\" parent=\"/drugs/magnesium-sulfate\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<sectiondiv outputclass=\"additionalCautions\">\n<sectiondiv outputclass=\"cautionsOrContraindicationsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"caution\">in rapid bowel evacuation&#8212;elderly and debilitated patients</ph> (in adults)</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71474\" outputclass=\"interactions\" rev=\"1.8\" parent=\"/drugs/magnesium-sulfate\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (magnesium, parenteral).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71421\" outputclass=\"sideEffects\" rev=\"1.21\" parent=\"/drugs/magnesium-sulfate\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<title>General side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Arrhythmias</ph>; <ph outputclass=\"sideEffect\">coma</ph>; <ph outputclass=\"sideEffect\">confusion</ph>; <ph outputclass=\"sideEffect\">drowsiness</ph>; <ph outputclass=\"sideEffect\">flushing of skin</ph>; <ph outputclass=\"sideEffect\">hypermagnesaemia associated side-effects</ph>; <ph outputclass=\"sideEffect\">hypotension</ph>; <ph outputclass=\"sideEffect\">loss of tendon reflexes</ph>; <ph outputclass=\"sideEffect\">muscle weakness</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">respiratory depression</ph>; <ph outputclass=\"sideEffect\">thirst</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"specificSideEffects\">\n<title>Specific side-effects:</title>\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<sectiondiv outputclass=\"sideEffectsWithRoutes\">\n<p outputclass=\"title\">With oral use</p>\n<p>\n<ph outputclass=\"sideEffect\">colic</ph>; <ph outputclass=\"sideEffect\">diarrhoea</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71465\" outputclass=\"pregnancy\" parent=\"/drugs/magnesium-sulfate\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p outputclass=\"specificity\">When used for <ph outputclass=\"indication\">Hypomagnesaemia</ph> or <ph outputclass=\"indication\">Arrhythmias</ph> or <ph outputclass=\"indication\">Prevention of seizures in pre-eclampsia</ph> or <ph outputclass=\"indication\">Treatment of seizures and prevention of seizure recurrence in eclampsia</ph> or <ph outputclass=\"indication\">Severe acute asthma</ph> or <ph outputclass=\"indication\">Continuing respiratory deterioration in anaphylaxis</ph> in adults</p>\n<p>Not known to be harmful for short-term intravenous administration in eclampsia, but excessive doses in third trimester cause neonatal respiratory depression.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">When used for <ph outputclass=\"indication\">Neonatal hypocalcaemia</ph> or <ph outputclass=\"indication\">Hypomagnesaemia</ph> or <ph outputclass=\"indication\">Torsade de pointes</ph> or <ph outputclass=\"indication\">Severe acute asthma</ph> or <ph outputclass=\"indication\">Continuing respiratory deterioration in anaphylaxis</ph> in children</p>\n<p>Sufficient amount may cross the placenta in mothers treated with high doses e.g. in pre-eclampsia, causing hypotonia and respiratory depression in newborns.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71549\" outputclass=\"hepaticImpairment\" parent=\"/drugs/magnesium-sulfate\">\n<title>Hepatic impairment</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid in hepatic coma if risk of renal failure.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71441\" outputclass=\"renalImpairment\" parent=\"/drugs/magnesium-sulfate\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>Avoid or reduce dose.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Increased risk of toxicity.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71400\" outputclass=\"monitoringRequirements\" parent=\"/drugs/magnesium-sulfate\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor blood pressure, respiratory rate, urinary output and for signs of overdosage (loss of patellar reflexes, weakness, nausea, sensation of warmth, flushing, drowsiness, double vision, and slurred speech).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71719\" outputclass=\"directionsForAdministration\" rev=\"1.43\" parent=\"/drugs/magnesium-sulfate\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For <i>intravenous infusion</i>, in persistent pulmonary hypertension of the newborn, dilute to a max. concentration of 100&#8239;mg/mL (10%) (0.4&#8239;mmol/ mL Mg<sup>2+</sup>) magnesium sulfate heptahydrate (200&#8239;mg/ mL (0.8&#8239;mmol/mL Mg<sup>2+</sup>) if fluid restricted) with Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>In severe hypomagnesaemia administer initially via controlled infusion device (preferably syringe pump).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in adults</p>\n<p>For <i>intravenous injection</i>, in arrhythmias, hypomagnesaemia, eclampsia, and pre-eclampsia, give continuously in Glucose 5% or Sodium chloride 0.9%.</p>\n<p>Concentration of magnesium sulfate heptahydrate should not exceed 20% (200&#8239;mg/mL or 0.8&#8239;mmol/mL Mg<sup>2+</sup>); dilute 1 part of magnesium sulfate injection 50% with at least 1.5 parts of water for injections.</p>\n<p>Max. rate 150&#8239;mg/minute (0.6&#8239;mmol/minute Mg<sup>2+</sup>).</p>\n</sectiondiv>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intravenous</ph> use in children</p>\n<p>For neonatal hypocalcaemia, hypomagnaesemia, and torsade de pointes, dilute to 10% (100&#8239;mg magnesium sulfate heptahydrate (0.4&#8239;mmol Mg<sup>2+</sup>) in 1&#8239;mL) with Glucose 5% <i>or</i> 10%, Sodium Chloride 0.45% <i>or</i> 0.9% <i>or</i> Glucose and Sodium Chloride combinations. Up to 20% solution may be given in fluid restriction. Rate of administration should not exceed 10&#8239;mg/kg/minute (0.04&#8239;mmol/kg/minute Mg<sup>2+</sup>) of magnesium sulfate heptahydrate.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60544\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.14\" parent=\"/drugs/magnesium-sulfate\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use</p>\n<p>The BP directs that the label states the strength as the % w/v of magnesium sulfate heptahydrate and as the approximate concentration of magnesium ions (Mg<sup>2+</sup>) in mmol/mL.</p>\n<p>Magnesium Sulfate Injection BP is a sterile solution of Magnesium Sulfate Heptahydrate.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP71375\" outputclass=\"exceptionsToLegalCategory\" rev=\"1.8\" parent=\"/drugs/magnesium-sulfate\">\n<title>Exceptions to legal category</title>\n<body>\n<section>\n<sectiondiv>\n<p outputclass=\"specificity\">With <ph outputclass=\"route\">oral</ph> use in adults</p>\n<p>Magnesium sulfate is on sale to the public as Epsom Salts.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP6120-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/magnesium-sulfate\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: solution for injection, cutaneous solution, solution for infusion, capsule, infusion</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77835\" title=\"Solution for injection\" namespace=\"/drugs/magnesium-sulfate/solution-for-injection\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77825\" title=\"Solution for infusion\" namespace=\"/drugs/magnesium-sulfate/solution-for-infusion\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77812\" title=\"Powder\" namespace=\"/drugs/magnesium-sulfate/powder\">Powder</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"2\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78099\" namespace=\"/treatment-summaries/hypertension\" title=\"Hypertension\" count=\"1\" rel=\"backlink\">Hypertension</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78111\" namespace=\"/treatment-summaries/antihistamines-allergen-immunotherapy-and-allergic-emergencies\" title=\"Antihistamines, allergen immunotherapy and allergic emergencies\" count=\"1\" rel=\"backlink\">Antihistamines, allergen immunotherapy and allergic emergencies</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78233\" namespace=\"/treatment-summaries/constipation\" title=\"Constipation\" count=\"1\" rel=\"backlink\">Constipation</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78291\" namespace=\"/treatment-summaries/arrhythmias\" title=\"Arrhythmias\" count=\"1\" rel=\"backlink\">Arrhythmias</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78341\" namespace=\"/treatment-summaries/minerals\" title=\"Minerals\" count=\"8\" rel=\"backlink\">Minerals</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78360\" namespace=\"/treatment-summaries/asthma\" title=\"Asthma\" count=\"4\" rel=\"backlink\">Asthma</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_608\" namespace=\"/interactions/list-of-drug-interactions/magnesium-parenteral\" title=\"Magnesium (parenteral)\" count=\"1\" rel=\"link\">Magnesium (parenteral)</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77835\" namespace=\"/drugs/magnesium-sulfate/solution-for-injection\" title=\"Solution for injection\" count=\"1\" rel=\"link\">Solution for injection</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77825\" namespace=\"/drugs/magnesium-sulfate/solution-for-infusion\" title=\"Solution for infusion\" count=\"1\" rel=\"link\">Solution for infusion</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77812\" namespace=\"/drugs/magnesium-sulfate/powder\" title=\"Powder\" count=\"1\" rel=\"link\">Powder</xref>\n</links>\n</topic>",
    "id": "PHP6120",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/magnesium-sulfate",
    "basename": "magnesium-sulfate",
    "title": "MAGNESIUM SULFATE",
    "interactants": [
        {
            "id": "bnf_int_608",
            "label": "Magnesium (parenteral)"
        }
    ],
    "vtmid": "37400007",
    "drugClassification": [
        "Magnesium",
        "Osmotic laxatives"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "secondaryDomainsOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Severe acute asthma",
                        "html": "Severe acute asthma"
                    },
                    {
                        "textContent": "Continuing respiratory deterioration in anaphylaxis",
                        "html": "Continuing respiratory deterioration in anaphylaxis"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "child": [
                    {
                        "textContent": "40 mg/kg (max. per dose 2 g), to be given over 20 minutes.",
                        "html": "<p>40&#8239;mg/kg (max. per dose 2&#8239;g), to be given over 20 minutes.</p>",
                        "ageGroup": "2&#8211;17 years"
                    }
                ],
                "adult": [
                    {
                        "textContent": "1.2&#8211;2 g, to be given over 20 minutes.",
                        "html": "<p>1.2&#8211;2&#8239;g, to be given over 20 minutes.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prevention of seizures in pre-eclampsia",
                        "html": "Prevention of seizures in pre-eclampsia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 4 g, to be given over 5&#8211;15 minutes, followed by (by intravenous infusion) 1 gram/hour for 24 hours, if seizure occurs, additional dose of 2 g by intravenous injection to be administered.",
                        "html": "<p>Initially 4&#8239;g, to be given over 5&#8211;15 minutes, followed by (by intravenous infusion) 1&#8239;gram/hour for 24 hours, if seizure occurs, additional dose of 2&#8239;g by intravenous injection to be administered.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of seizures and prevention of seizure recurrence in eclampsia",
                        "html": "Treatment of seizures and prevention of seizure recurrence in eclampsia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially intravenous injection"
                    ],
                    "textContent": "Initially by intravenous injection",
                    "html": "Initially by intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "Initially 4 g, to be given over 5&#8211;15 minutes, followed by (by intravenous infusion) 1 gram/hour for 24 hours after seizure or delivery (whichever is later), if seizure recurs, increase the infusion rate to 1.5&#8211;2 g/hour or give an additional dose of 2 g by intravenous injection.",
                        "html": "<p>Initially 4&#8239;g, to be given over 5&#8211;15 minutes, followed by (by intravenous infusion) 1&#8239;gram/hour for 24 hours after seizure or delivery (whichever is later), if seizure recurs, increase the infusion rate to 1.5&#8211;2&#8239;g/hour or give an additional dose of 2&#8239;g by intravenous injection.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Hypomagnesaemia",
                        "html": "Hypomagnesaemia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion or intramuscular injection"
                    ],
                    "textContent": "By intravenous infusion or by intramuscular injection",
                    "html": "By intravenous infusion or by intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "Up to 40 g, dose given over up to 5 days may be required to replace the deficit (allowing for urinary losses).",
                        "html": "<p>Up to 40&#8239;g, dose given over up to 5 days may be required to replace the deficit (allowing for urinary losses).</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Hypomagnesaemia maintenance (e.g. in intravenous nutrition)",
                        "html": "Hypomagnesaemia maintenance (e.g. in intravenous nutrition)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion or intramuscular injection"
                    ],
                    "textContent": "By intravenous infusion or by intramuscular injection",
                    "html": "By intravenous infusion or by intramuscular injection"
                },
                "adult": [
                    {
                        "textContent": "2.5&#8211;5 g daily, usual dose 3 g daily.",
                        "html": "<p>2.5&#8211;5&#8239;g daily, usual dose 3&#8239;g daily.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Emergency treatment of serious arrhythmias",
                        "html": "Emergency treatment of serious arrhythmias"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous injection"
                    ],
                    "textContent": "By intravenous injection",
                    "html": "By intravenous injection"
                },
                "adult": [
                    {
                        "textContent": "2 g, to be given over 10-15 minutes, dose may be repeated once if necessary.",
                        "html": "<p>2&#8239;g, to be given over 10-15 minutes, dose may be repeated once if necessary.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Rapid bowel evacuation (acts in 2&#8211;4 hours)",
                        "html": "Rapid bowel evacuation (acts in 2&#8211;4 hours)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "5&#8211;10 g, dose to be mixed in a glass of water, taken preferably before breakfast.",
                        "html": "<p>5&#8211;10&#8239;g, dose to be mixed in a glass of water, taken preferably before breakfast.</p>"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Magnesium sulfate heptahydrate 1 g equivalent to Mg2+ approx. 4 mmol.",
                "html": "<p>Magnesium sulfate heptahydrate 1&#8239;g equivalent to Mg<sup>2+</sup> approx. 4&#8239;mmol.</p>"
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "Unlicensed indication in severe acute asthma.\n\nContinuing respiratory deterioration in anaphylaxis.",
                "html": "<p>Unlicensed indication in severe acute asthma.</p><p>Continuing respiratory deterioration in anaphylaxis.</p>"
            }
        ]
    },
    "contraindications": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "in rapid bowel evacuation&#8212;acute gastro-intestinal conditions in adults",
                "html": "in rapid bowel evacuation&#8212;acute gastro-intestinal conditions in adults",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ],
                    "patientType": "adults"
                }
            }
        ]
    },
    "cautions": {
        "cautionsOrContraindicationsWithRoutes": [
            {
                "type": "cautionsOrContraindicationsWithRoutes",
                "textContent": "in rapid bowel evacuation&#8212;elderly and debilitated patients in adults",
                "html": "in rapid bowel evacuation&#8212;elderly and debilitated patients in adults",
                "specificity": {
                    "textContent": "With oral use",
                    "html": "With oral use",
                    "routes": [
                        "oral"
                    ],
                    "patientType": "adults"
                }
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (magnesium, parenteral).",
                "html": "<p>Appendix 1 (magnesium, parenteral).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Arrhythmias",
                        "html": "Arrhythmias",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "coma",
                        "html": "coma",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "confusion",
                        "html": "confusion",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "drowsiness",
                        "html": "drowsiness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flushing of skin",
                        "html": "flushing of skin",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypermagnesaemia associated side-effects",
                        "html": "hypermagnesaemia associated side-effects",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "hypotension",
                        "html": "hypotension",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "loss of tendon reflexes",
                        "html": "loss of tendon reflexes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "muscle weakness",
                        "html": "muscle weakness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "respiratory depression",
                        "html": "respiratory depression",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "thirst",
                        "html": "thirst",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "specific": {
            "frequencies": {
                "notKnown": [
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "colic",
                        "html": "colic",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    },
                    {
                        "type": "sideEffectsWithRoutes",
                        "textContent": "diarrhoea",
                        "html": "diarrhoea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "With oral use",
                            "html": "With oral use",
                            "routes": [
                                "oral"
                            ]
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "When used for Hypomagnesaemia or Arrhythmias or Prevention of seizures in pre-eclampsia or Treatment of seizures and prevention of seizure recurrence in eclampsia or Severe acute asthma or Continuing respiratory deterioration in anaphylaxis in adults",
                    "html": "When used for <ph outputclass=\"indication\">Hypomagnesaemia</ph> or <ph outputclass=\"indication\">Arrhythmias</ph> or <ph outputclass=\"indication\">Prevention of seizures in pre-eclampsia</ph> or <ph outputclass=\"indication\">Treatment of seizures and prevention of seizure recurrence in eclampsia</ph> or <ph outputclass=\"indication\">Severe acute asthma</ph> or <ph outputclass=\"indication\">Continuing respiratory deterioration in anaphylaxis</ph> in adults",
                    "patientType": "pre-eclampsia or Treatment of seizures and prevention of seizure recurrence in eclampsia or Severe acute asthma or Continuing respiratory deterioration in anaphylaxis in adults",
                    "indications": [
                        "Hypomagnesaemia",
                        "Arrhythmias",
                        "Prevention of seizures in pre-eclampsia",
                        "Treatment of seizures and prevention of seizure recurrence in eclampsia",
                        "Severe acute asthma",
                        "Continuing respiratory deterioration in anaphylaxis"
                    ]
                },
                "textContent": "Not known to be harmful for short-term intravenous administration in eclampsia, but excessive doses in third trimester cause neonatal respiratory depression.",
                "html": "<p>Not known to be harmful for short-term intravenous administration in eclampsia, but excessive doses in third trimester cause neonatal respiratory depression.</p>"
            },
            {
                "type": "generalInformation",
                "specificity": {
                    "textContent": "When used for Neonatal hypocalcaemia or Hypomagnesaemia or Torsade de pointes or Severe acute asthma or Continuing respiratory deterioration in anaphylaxis in children",
                    "html": "When used for <ph outputclass=\"indication\">Neonatal hypocalcaemia</ph> or <ph outputclass=\"indication\">Hypomagnesaemia</ph> or <ph outputclass=\"indication\">Torsade de pointes</ph> or <ph outputclass=\"indication\">Severe acute asthma</ph> or <ph outputclass=\"indication\">Continuing respiratory deterioration in anaphylaxis</ph> in children",
                    "patientType": "anaphylaxis in children",
                    "indications": [
                        "Neonatal hypocalcaemia",
                        "Hypomagnesaemia",
                        "Torsade de pointes",
                        "Severe acute asthma",
                        "Continuing respiratory deterioration in anaphylaxis"
                    ]
                },
                "textContent": "Sufficient amount may cross the placenta in mothers treated with high doses e.g. in pre-eclampsia, causing hypotonia and respiratory depression in newborns.",
                "html": "<p>Sufficient amount may cross the placenta in mothers treated with high doses e.g. in pre-eclampsia, causing hypotonia and respiratory depression in newborns.</p>"
            }
        ]
    },
    "hepaticImpairment": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid in hepatic coma if risk of renal failure.",
                "html": "<p>Avoid in hepatic coma if risk of renal failure.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "Avoid or reduce dose.",
                "html": "<p>Avoid or reduce dose.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Increased risk of toxicity.",
                "html": "<p>Increased risk of toxicity.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor blood pressure, respiratory rate, urinary output and for signs of overdosage (loss of patellar reflexes, weakness, nausea, sensation of warmth, flushing, drowsiness, double vision, and slurred speech).",
                "html": "<p>Monitor blood pressure, respiratory rate, urinary output and for signs of overdosage (loss of patellar reflexes, weakness, nausea, sensation of warmth, flushing, drowsiness, double vision, and slurred speech).</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous infusion, in persistent pulmonary hypertension of the newborn, dilute to a max. concentration of 100 mg/mL (10%) (0.4 mmol/ mL Mg2+) magnesium sulfate heptahydrate (200 mg/ mL (0.8 mmol/mL Mg2+) if fluid restricted) with Glucose 5% or Sodium Chloride 0.9%.",
                "html": "<p>For <i>intravenous infusion</i>, in persistent pulmonary hypertension of the newborn, dilute to a max. concentration of 100&#8239;mg/mL (10%) (0.4&#8239;mmol/ mL Mg<sup>2+</sup>) magnesium sulfate heptahydrate (200&#8239;mg/ mL (0.8&#8239;mmol/mL Mg<sup>2+</sup>) if fluid restricted) with Glucose 5% <i>or</i> Sodium Chloride 0.9%.</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "In severe hypomagnesaemia administer initially via controlled infusion device (preferably syringe pump).",
                "html": "<p>In severe hypomagnesaemia administer initially via controlled infusion device (preferably syringe pump).</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in adults",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For intravenous injection, in arrhythmias, hypomagnesaemia, eclampsia, and pre-eclampsia, give continuously in Glucose 5% or Sodium chloride 0.9%.\n\nConcentration of magnesium sulfate heptahydrate should not exceed 20% (200 mg/mL or 0.8 mmol/mL Mg2+); dilute 1 part of magnesium sulfate injection 50% with at least 1.5 parts of water for injections.\n\nMax. rate 150 mg/minute (0.6 mmol/minute Mg2+).",
                "html": "<p>For <i>intravenous injection</i>, in arrhythmias, hypomagnesaemia, eclampsia, and pre-eclampsia, give continuously in Glucose 5% or Sodium chloride 0.9%.</p><p>Concentration of magnesium sulfate heptahydrate should not exceed 20% (200&#8239;mg/mL or 0.8&#8239;mmol/mL Mg<sup>2+</sup>); dilute 1 part of magnesium sulfate injection 50% with at least 1.5 parts of water for injections.</p><p>Max. rate 150&#8239;mg/minute (0.6&#8239;mmol/minute Mg<sup>2+</sup>).</p>"
            },
            {
                "type": "directionsForAdministration",
                "specificity": {
                    "textContent": "With intravenous use in children",
                    "html": "With <ph outputclass=\"route\">intravenous</ph> use in children",
                    "patientType": "children",
                    "routes": [
                        "intravenous"
                    ]
                },
                "textContent": "For neonatal hypocalcaemia, hypomagnaesemia, and torsade de pointes, dilute to 10% (100 mg magnesium sulfate heptahydrate (0.4 mmol Mg2+) in 1 mL) with Glucose 5% or 10%, Sodium Chloride 0.45% or 0.9% or Glucose and Sodium Chloride combinations. Up to 20% solution may be given in fluid restriction. Rate of administration should not exceed 10 mg/kg/minute (0.04 mmol/kg/minute Mg2+) of magnesium sulfate heptahydrate.",
                "html": "<p>For neonatal hypocalcaemia, hypomagnaesemia, and torsade de pointes, dilute to 10% (100&#8239;mg magnesium sulfate heptahydrate (0.4&#8239;mmol Mg<sup>2+</sup>) in 1&#8239;mL) with Glucose 5% <i>or</i> 10%, Sodium Chloride 0.45% <i>or</i> 0.9% <i>or</i> Glucose and Sodium Chloride combinations. Up to 20% solution may be given in fluid restriction. Rate of administration should not exceed 10&#8239;mg/kg/minute (0.04&#8239;mmol/kg/minute Mg<sup>2+</sup>) of magnesium sulfate heptahydrate.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "specificity": {
                    "textContent": "With intramuscular use or intravenous use",
                    "html": "With <ph outputclass=\"route\">intramuscular</ph> use or <ph outputclass=\"route\">intravenous</ph> use",
                    "routes": [
                        "intramuscular",
                        "intravenous"
                    ]
                },
                "textContent": "The BP directs that the label states the strength as the % w/v of magnesium sulfate heptahydrate and as the approximate concentration of magnesium ions (Mg2+) in mmol/mL.\n\nMagnesium Sulfate Injection BP is a sterile solution of Magnesium Sulfate Heptahydrate.",
                "html": "<p>The BP directs that the label states the strength as the % w/v of magnesium sulfate heptahydrate and as the approximate concentration of magnesium ions (Mg<sup>2+</sup>) in mmol/mL.</p><p>Magnesium Sulfate Injection BP is a sterile solution of Magnesium Sulfate Heptahydrate.</p>"
            }
        ]
    },
    "exceptionsToLegalCategory": {
        "exceptionsToLegalCategory": [
            {
                "type": "exceptionsToLegalCategory",
                "specificity": {
                    "textContent": "With oral use in adults",
                    "html": "With <ph outputclass=\"route\">oral</ph> use in adults",
                    "patientType": "adults",
                    "routes": [
                        "oral"
                    ]
                },
                "textContent": "Magnesium sulfate is on sale to the public as Epsom Salts.",
                "html": "<p>Magnesium sulfate is on sale to the public as Epsom Salts.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "solution for injection",
                "cutaneous solution",
                "solution for infusion",
                "capsule",
                "infusion"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77835",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77825",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77812",
                "label": "Powder",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78099",
                "label": "Hypertension",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78111",
                "label": "Antihistamines, allergen immunotherapy and allergic emergencies",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78233",
                "label": "Constipation",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78291",
                "label": "Arrhythmias",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78341",
                "label": "Minerals",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78360",
                "label": "Asthma",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_608",
                "label": "Magnesium (parenteral)",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77835",
                "label": "Solution for injection",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77825",
                "label": "Solution for infusion",
                "type": "medicinalForm"
            },
            {
                "id": "PHP77812",
                "label": "Powder",
                "type": "medicinalForm"
            }
        ]
    }
}